Universe Pharmaceuticals UPC
NASDAQ UPC
$5.18 -0.15 (-2.81%)
As of: Aug 21, 2026 · 9:30 AM EDT

Universe Pharmaceuticals (UPC) Retained Earnings (2020 - 2026)

Universe Pharmaceuticals (UPC) posted Retained Earnings of -$15.4 million for Q1 2026, down 11.23% sequentially from -$13.8 million in Q3 2025.

Universe Pharmaceuticals (UPC) Retained Earnings (2020 - 2026) Analysis & Trends

Universe Pharmaceuticals has reported Retained Earnings for 7 years, with the latest figure at -$15.4 million in Q1 2026.

  • Quarterly Retained Earnings changed N/A year-over-year to -$15.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$15.4 million (changed N/A YoY) and the FY2025 annual result came in at -$13.8 million, up 99.86% from the prior year.
  • Retained Earnings slipped to -$15.4 million in Q1 2026 per UPC's latest filing, from -$13.8 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $26.8 million in Q1 2022 and troughed at -$10.2 billion in Q3 2024.
  • A 5-year average of -$1.3 billion and a median of -$2.2 million in 2023 frame the typical range for Retained Earnings.
  • The sharpest annual moves came in 2024 and 2025: Retained Earnings plunged 428674.83% in 2024, then soared 99.86% in 2025.
  • Over 5 years, Retained Earnings stood at $16.3 million in 2022, then sank by 114.53% to -$2.4 million in 2023, then slumped by 428674.83% to -$10.2 billion in 2024, then jumped by 99.86% to -$13.8 million in 2025, then slipped by 11.23% to -$15.4 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$15.4 million, -$13.8 million, and -$10.2 billion for Q1 2026, Q3 2025, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Haleon 44.03 Bn 43.06 Bn - 37.15 Bn
2 Teva Pharmaceutical Industries 42.97 Bn 39.31 Bn 2.15 Bn 28.26 Bn
3 Zoetis 31.63 Bn 29.95 Bn 1.05 Bn 14.65 Bn
4 Takeda Pharmaceutical 28.54 Bn 22.74 Bn 5.10 Bn 4.18 Bn
5 United Therapeutics 22.33 Bn 19.67 Bn 683.80 Mn 9.16 Bn
6 Viatris 18.68 Bn 17.80 Bn 1.46 Bn 18.56 Bn
7 Neurocrine Biosciences 15.53 Bn 15.14 Bn 935.80 Mn 724.00 Mn
8 Elanco Animal Health 11.89 Bn 11.36 Bn 798.00 Mn 8.88 Bn
9 Dr Reddys Laboratories 10.08 Bn 9.92 Bn - 3.75 Bn
10 Universe Pharmaceuticals 2.92 Mn -26.13 Mn - -15.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -15.40 Mn
Sep 30, 2025 -13.84 Mn
Sep 30, 2024 -10.17 Bn
Mar 31, 2024 -2.10 Mn
Sep 30, 2023 -2.37 Mn
Mar 31, 2023 -266,930.00
Sep 30, 2022 16.32 Mn
Mar 31, 2022 26.79 Mn
Sep 30, 2021 29.28 Mn
Sep 30, 2020 13,738.98 Bn